oxycodone has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, M; Conway, B; Dylla, DE; Khan, T; Marcinak, J; Martinez, A; Saget, B | 1 |
| Bian, J; Butera, JN; Di, M | 1 |
2 other study(ies) available for oxycodone and Chronic Hepatitis C
| Article | Year |
|---|---|
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
Topics: Analgesics, Opioid; Antiviral Agents; Fentanyl; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Hydrocodone; Oxycodone; Sofosbuvir | 2023 |
A new onset of thrombocytopenia and microangiopathic hemolytic anemia in the healthcare setting: A challenge for diagnosis.
Topics: Abscess; Adult; Analgesics, Opioid; Anemia, Hemolytic; Anti-Bacterial Agents; Catheterization, Central Venous; Creatinine; Diabetes Mellitus, Type 1; Diagnosis, Differential; Fasciitis, Necrotizing; Hepatitis C, Chronic; Humans; Length of Stay; Male; Oxycodone; Plasma Exchange; Substance-Related Disorders; Thrombocytopenia; Venous Thrombosis | 2019 |